[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vaginal-delivery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vaginal-delivery":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,63,90,134,160,180,201,230,256],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":37,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":62},"100641975","use-of-perineal-mirror-during-the-second-stage-of-labor-100641975",false,"NCT07659249","USE OF PERINEAL MIRROR DURING THE SECOND STAGE OF LABOR","THE EFFECT OF PERİNEAL MİRROR USE DURİNG THE SECOND STAGE OF LABOR ON THE DURATİON OF THE SECOND STAGE, RECOVERY, AND PERCEİVED PAİN, SUPPORT, AND CONTROL LEVELS DURİNG DELİVERY","Inclusion Criteria:\n\n* Women aged 19 and over\n* Women with term pregnancy (38+0 - 41+6)\n* Women with singleton pregnancy\n* Women who have had spontaneous vaginal delivery\n* Primiparous pregnant women\n* Women who voluntarily agree to participate in the study will be included.\n\nExclusion Criteria:\n\n* Women with high-risk pregnancies\n* Women with multiple pregnancies",true,"FEMALE","19 Years","49 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","Objective: This study was designed to evaluate the effect of perineal mirror use during the second stage of labor on the duration of the second stage, postpartum recovery, and perceived pain, support, and control levels during delivery.\n\nMethod: The study was designed as a randomized controlled experimental study to examine the effect of perineal mirror use on delivery outcomes in primiparous women. The study population consisted of primiparous pregnant women admitted to the maternity clinic between June 29, 2026, and October 30, 2026. The sample size was calculated using the G\\*Power 3.1.9.2 program with an effect size of 0.50, 5% Type I error, and 95% power level; a total of 72 participants were selected, 36 in the intervention group and 36 in the control group. Considering potential losses, the sample size was increased by 10%, and a total of 80 pregnant women were planned to be included in the study. Participants were randomly assigned to the intervention group using a perineal mirror and the control group receiving routine care. The following instruments will be used as data collection tools: Pregnancy Demographic Information Form, REEDA Scale, Visual Analog Scale (VAS), and Perceived Support and Control in Childbirth Scale.\n\nExpected Outcome: It is predicted that the perineal mirror may increase the woman's active participation, motivation, and perceived control by allowing her to see the fetal descent and the progress of labor; consequently, it may reduce the duration of active pushing and the duration of the second stage. It is also thought that it may have positive effects on the birth experience, postpartum recovery, and perceived level of support and control. The research results are expected to provide evidence for non-invasive and low-cost applications that can be used in childbirth care.",[28,29,30,31,32,33,34,35,36],"Labor, Second Stage","Vaginal Delivery","Primiparity","Perineal Mirror Use","Childbirth Experience","Labor Pain","Perceived Support During Childbirth","Perceived Control During Childbirth","Postpartum Perineal Healing",[38,39,40,41,42,43,44,45,46,47,48,49],"Midwifery","Perineal mirror","Second stage of labor","Vaginal birth","Primiparous women","Labor duration","Childbirth pain","Perceived support","Perceived control","REEDA scale","Maternal outcomes","Non-invasive intervention","NOT_YET_RECRUITING","2026-06-18",{"date":53,"type":54},"2026-06-22","ACTUAL",{"date":56,"type":22},"2026-06-29",{"date":58,"type":22},"2026-10-30",{"name":60,"class":61},"Sakarya University","OTHER",1,{"id":64,"slug":65,"hasResults":11,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":4,"eligibilityCriteria":69,"healthyVolunteers":16,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":76,"conditions":77,"keywords":78,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":62},"100616697","practice-of-assisted-vaginal-birth-in-egypt-100616697","NCT07308977","Practice of Assisted Vaginal Birth in Egypt","Factors Affecting the Practice of Assisted Vaginal Birth in Three Tertiary Level Hospitals in Egypt. A Cross-Sectional Study","Inclusion Criteria:\n\n* Obstetricians with at least 3 years of experience in practicing obstetrics\n* Obstetricians with their primary health care facility being one of the three Tertiary centres, Ain Shams University Maternity Hospital, El Hussein University Hospital, and El Kasr Alaini Hospital\n\nExclusion Criteria:\n\n\\-","ALL","28 Years","60 Years",{"count":74,"type":22},150,"OBSERVATIONAL","In Egypt, the proportion of CSs has been steadily increasing in recent years and has reached an alarming level. According to data from the Royal College of Obstetricians and Gynaecologists (RCOG), approximately 6% of caesarean sections (CS) are performed on average because of inadequate supervision from junior staff members or a lack of training, particularly during the critical decision-making phase of this second stage. The unfamiliarity and lack of experience with operative vaginal delivery is a major cause for the rise in the rate of second stage caesarean section. This survey targets obstetricians with different levels of experience to find practical solutions to increase the rate of assisted vaginal delivery which subsequently will decrease the rate of second stage CS.",[29],[79],"Assisted vaginal delivery","RECRUITING","2026-05-10",{"date":83,"type":54},"2026-05-12",{"date":85,"type":54},"2026-01-15",{"date":87,"type":22},"2026-07-15",{"name":89,"class":61},"Ain Shams Maternity Hospital",{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":16,"sex":70,"minAge":4,"maxAge":97,"enrollmentInfo":98,"targetDuration":4,"studyType":23,"phases":100,"briefSummary":101,"conditions":102,"keywords":117,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":133},"100609268","infant-microbiota-restoration-with-maternal-microbes-100609268","NCT07212361","Infant Microbiota Restoration With Maternal Microbes","MaMi","Inclusion Criteria:\n\n* Healthy mother and healthy pregnancy\n* Singleton pregnancy,\n* Mothers who speak Finnish or Swedish\n* Mothers who are planning to breastfeed or give breastmilk by bottle to the infant\n* Infants who are expected to be healthy and who will not require BCG vaccination.\n\nExclusion Criteria:\n\n* Participants who lives further than a 2-hour drive from Meilahti, Helsinki, Finland\n* Mothers who are not planning to breastfeed or feed breastmilk by bottle to the infant\n* Mothers who are diagnosed with gestational diabetes, pre-eclampsia or who have been receiving antibiotics during the pregnancy or delivery\n* Premature infants born before the pregnancy week 37\n* Infants, who are born by urgent cesarean section or emergency cesarean section\n* Infants, who receive antibiotics during the first week of life\n* Infants, who are diagnosed with a disease, congenital anomaly or who receive less than 9 Apgar points at 5 minutes.\n* Infants, who receive BCG-vaccine","50 Years",{"count":99,"type":22},100,[25],"The goal of this clinical trial is to test the ability of different bacterial products in restoring natural gut microbiota in C-section born infants. The main question it aims to answer is:\n\nDo maternally derived strains of bacteria perform better than commercially available probiotic strains in restoring the gut microbiota of C-section born infants? Researchers will compare the gut microbiota of treated infants to that of untreated C-section born infants and untreated vaginally born infants to see if the bacterial treatments cause the microbiota to resemble that of vaginally born infants.\n\nParticipants will be given a bacterial product orally once daily for either one or four weeks and be asked to collect faecal, urine and saliva samples.",[103,104,105,106,107,29,108,109,110,111,112,113,114,115,116],"Infant, Newborn","Gut -Microbiota","Gut Dysbiosis","Cesarean Delivery Affecting Newborn","Cesarean Section","Gastrointestinal Microbiota","Microbiota, Cesarean Section, Probiotics, Dysbiosis","Feces","Delivery, Obstetric","Microbiota","Microbiology","Humans","Pregnancy","Neonate",[118,119,120,121,122,123],"Infant","newborn","cesarean section","neonate","restore","gut microbiota","2025-09-30",{"date":126,"type":54},"2025-10-08",{"date":128,"type":54},"2025-07-17",{"date":130,"type":22},"2035-12-31",{"name":132,"class":61},"University of Helsinki",2,{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":140,"eligibilityCriteria":141,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":142,"targetDuration":4,"studyType":23,"phases":144,"briefSummary":146,"conditions":147,"keywords":149,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":158,"locationsCount":62},"100579365","phase-4-comparative-analysis-of-analgesic-efficacy-by-single-shot-intrathecal-analgesia-sssa-in-normal-labor-100579365","NCT06823349","Comparative Analysis of Analgesic Efficacy: by Single Shot Intrathecal Analgesia (SSSA) in Normal Labor","Comparative Analysis of Analgesic Efficacy and Maternal Satisfaction: Single Shot Intrathecal Bupivacaine With Fentanyl Versus Bupivacaine With Dexmedetomidine in Normal Labor, Randomized Control Clinical Trial","SSSA","Inclusion Criteria:\n\n* ASA I-II.\n* Uncomplicated pregnancy.\n* At term \\& singleton fetus.\n* Cervical dilatation \\> 5cm\n* Cephalic presentations\n\nExclusion Criteria:\n\n* Patient refusal.\n* Bleeding disorders and patients on anticoagulant drugs.\n* Infection at site of injection.\n* Spine deformity.\n* Allergy to any of study medications.",{"count":143,"type":22},90,[145],"PHASE4","the goal of this randomized control trial is to compare the effect of adding fentanyl v.s dexmedetomidine to bupivacaine in single shot spinal analgesia in achievement of analgesia by decreasing visual analogue scale, onset and increasing duration of analgesia in normal labor.",[29,148],"Normal Labor",[150,151],"painless normal labor","Single shot spinal analgesia in vaginal delivery","2025-07-29",{"date":154,"type":54},"2025-07-31",{"date":156,"type":54},"2025-02-01",{"date":154,"type":22},{"name":159,"class":61},"Jehan George Sadek",{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":165,"acronym":4,"eligibilityCriteria":166,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":167,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":169,"conditions":170,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":171,"lastUpdatePostDateStruct":172,"startDateStruct":174,"completionDateStruct":176,"leadSponsor":178,"locationsCount":4},"100598773","outcomes-of-delivery-in-primigravida-100598773","NCT07075848","Outcomes of Delivery in Primigravida","Study of Outcomes of Delivery in Primgravida","Inclusion Criteria:\n\n* Primigravida women admitted for delivery at the hospital\n* Singleton pregnancies.\n* Gestational age ≥ 28 weeks (to exclude preterm deliveries before viability).\n* Willingness to participate.\n\nExclusion Criteria:\n\n* • Multiparous women.\n\n  * Multiple pregnancies.\n  * Women who decline to participate.\n  * Deliveries occurring outside the specified study period.",{"count":168,"type":22},200,"Primigravida women are a high-priority population due to their increased risk of obstetric interventions and adverse outcomes compared to multiparous women. Research indicates that first-time mothers account for a disproportionate number of emergency cesarean sections and instrumental deliveries, often due to factors such as inadequate labor support or failure to progress",[29],"2025-07-20",{"date":173,"type":54},"2025-07-24",{"date":175,"type":22},"2025-09-01",{"date":177,"type":22},"2028-01-01",{"name":179,"class":61},"Assiut University",{"id":181,"slug":182,"hasResults":11,"nctId":183,"briefTitle":184,"officialTitle":185,"acronym":4,"eligibilityCriteria":186,"healthyVolunteers":11,"sex":17,"minAge":187,"maxAge":188,"enrollmentInfo":189,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":190,"conditions":191,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":195,"completionDateStruct":197,"leadSponsor":199,"locationsCount":4},"100568406","factors-affecting-success-of-vaginal-birth-after-cesarean-section-100568406","NCT06680804","Factors Affecting Success of Vaginal Birth After Cesarean Section","Factors Affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals","Inclusion Criteria:\n\n* • Age from 20 to 40 years.\n\n  * Time interval more than 1.5 years from previous caesarean section.\n  * Single viable full-term pregnancy in vertex presentation.\n  * Reactive cardiotocography (CTG) on admission.\n  * Spontaneous labor onset.\n  * Clinically adequate pelvis.\n  * Single fetus\n  * Average AFI fetus\n\nExclusion Criteria:\n\n* • Women with previous upper segment cesarean section or hysterotomy scar.\n\n  * Any obstetric complications such as fetal malpresentation, placenta previa, or medical disorders like diabetes mellitus or preeclampsia.\n  * Presence of any signs and symptoms of scar dehiscence or ruptured uterus, known uterine fibroid or anomaly.\n  * Suspected fetal macrosomia (weight more than 4 kg).\n  * Multifetal pregnancy.\n  * Parturient women who refused the trial of vaginal birth after caesarean section.","20 Years","40 Years",{"count":62,"type":22},"Factors affecting Success of Vaginal Birth After Cesarean Section in Sohag University Hospitals",[29],"2024-11-07",{"date":194,"type":54},"2024-11-08",{"date":196,"type":22},"2024-12-01",{"date":198,"type":22},"2025-05-01",{"name":200,"class":61},"Sohag University",{"id":202,"slug":203,"hasResults":11,"nctId":204,"briefTitle":205,"officialTitle":206,"acronym":207,"eligibilityCriteria":208,"healthyVolunteers":11,"sex":17,"minAge":209,"maxAge":4,"enrollmentInfo":210,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":212,"conditions":213,"keywords":216,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":221,"lastUpdatePostDateStruct":222,"startDateStruct":224,"completionDateStruct":226,"leadSponsor":228,"locationsCount":4},"100561717","ultrasound-parameters-for-the-outcome-prediction-of-external-cephalic-version-for-fetuses-with-breech-presentation-100561717","NCT06593795","Ultrasound Parameters for the Outcome Prediction of External Cephalic Version for Fetuses with Breech Presentation","Prediction of External Cephalic Version Success in Case of Breech Presentation At Term of Pregnancy: a Prospective Observational Study","REVERSO","Inclusion Criteria:\n\n* Age ≥18 y.o.;\n* Pregnant women with a diagnosis of fetal breech presentation eligible and desirous for ECV;\n* Singleton;\n* At term (≥ 37 weeks);\n* Breech presentation;\n* No previous uterine scars or other indications for elective C-section;\n* Signed written informed consent to study participation.\n\nExclusion Criteria:\n\n* Age \\<18 y.o.;\n* Preterm gestational age;\n* Multiple pregnancies;\n* Indications for elective cesarean section;\n* Incomplete obstetrical data;\n* Refusal to provide informed consent.\n* Desire to an elective C-Section\n* Controindications for ECV or vaginal delivery (placental abruption, placenta previa, uterine malformations)\n* Reduction of amniotic fluid (AFI \\<4 cm)\n* Uterine contractions\n* Vaginal bleeding\n* Premature rupture of membranes\n* Nonreassuring fetal heart rate patterns before the procedure.","18 Years",{"count":211,"type":22},120,"This study aims to evaluate possible predictors for the successful od external cephalic version (ECV), a procedure that is indicated in your case due to breech presentation of your baby and your desire to avoid cesarean section. Before the procedure, a detailed ultrasound scan will be performed to measure several parameters. After the procedure we will collect data about the duration, outcome and eventual complications of ECV.",[214,215,29,107],"Breech Fetal Presentation","Breech Presentation of Fetus with Successful Version",[217,218,219,220],"breech","external cephalic version","ultrasound","c-section","2024-09-12",{"date":223,"type":54},"2024-09-19",{"date":225,"type":22},"2024-10",{"date":227,"type":22},"2026-10",{"name":229,"class":61},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS",{"id":231,"slug":232,"hasResults":11,"nctId":233,"briefTitle":234,"officialTitle":235,"acronym":4,"eligibilityCriteria":236,"healthyVolunteers":11,"sex":17,"minAge":209,"maxAge":188,"enrollmentInfo":237,"targetDuration":4,"studyType":23,"phases":239,"briefSummary":240,"conditions":241,"keywords":4,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":247,"lastUpdatePostDateStruct":248,"startDateStruct":250,"completionDateStruct":252,"leadSponsor":254,"locationsCount":62},"100559757","lignocaine-vs-bupivacaine-infiltration-for-postpartum-perineal-pain-after-vaginal-delivery-with-episiotomy-in-primigravidae-100559757","NCT06568289","Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae","Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae: A Prospective Randomized, Double-Blind, Clinical Trial","Inclusion Criteria:\n\n* Primigravidae with the full term undergoing vaginal delivery with episiotomy.\n* Pregnancies and singleton vertex cephalic fetuses.\n* In the active phase of the first stage of labor.\n\nExclusion Criteria:\n\n* Patients with history of drug allergies to study drugs as this will increase the risk of complications.\n* Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.\n* Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.\n* Inability to cooperate as this will affect our assessment.\n* Patient's refusal.\n* Any intraoperative complications that will affect our outcome criteria (bleeding, organ injury) as they will affect patient's vital data and affect our assessment.\n* Neurological comorbidities (chronic pain disorder, chronic systemic disease, neurological disorder, neuropathic pain) as they will need more analgesia.\n* Drug abuse as they will be tolerant to the used analgesics.",{"count":238,"type":22},60,[25],"In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.",[242,243,244,29,245,246],"Lignocaine","Bupivacaine","Postpartum Perineal Pain","Episiotomy","Primigravidae","2024-08-22",{"date":249,"type":54},"2024-08-23",{"date":251,"type":54},"2024-03-01",{"date":253,"type":22},"2024-09-01",{"name":255,"class":61},"Ain Shams University",{"id":257,"slug":258,"hasResults":11,"nctId":259,"briefTitle":260,"officialTitle":260,"acronym":4,"eligibilityCriteria":261,"healthyVolunteers":16,"sex":17,"minAge":209,"maxAge":262,"enrollmentInfo":263,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":264,"conditions":265,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":266,"lastUpdatePostDateStruct":267,"startDateStruct":269,"completionDateStruct":271,"leadSponsor":273,"locationsCount":62},"100519483","a-novel-approach-integrating-magnetic-resonance-imaging-mri-data-and-artificial-intelligence-for-predicting-the-success-rate-of-vaginal-delivery-in-pregnant-women-100519483","NCT06044129","A Novel Approach Integrating Magnetic Resonance Imaging (MRI) Data and Artificial Intelligence for Predicting the Success Rate of Vaginal Delivery in Pregnant Women","Inclusion Criteria:\n\n* Full-term.\n* Single fetus, head first.\n* Pregnant women have vaginal couvade wishes.\n* Complete clinical data of pregnant women.\n\nExclusion Criteria:\n\n* Pregnancy with serious medical and surgical diseases.\n* Abnormal fetal position (such as transverse, breech, etc.).\n* Twin or multiple pregnancies.\n* Vaginal couvade contraindications such as placenta previa.","35 Years",{"count":168,"type":22},"The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.",[29],"2023-09-12",{"date":268,"type":54},"2023-09-21",{"date":270,"type":22},"2024-01-01",{"date":272,"type":22},"2026-12-31",{"name":274,"class":61},"Second Affiliated Hospital of Wenzhou Medical University"]